IP Library Granted Patent US 10,549,029
Granted Patent B2
US 10,549,029 · App. 15/625,563 · Granted Feb 4, 2020

Drive mechanism for drug delivery pumps with integrated status indication

Inventors: Ryan M. Agard (Royersford, PA); Ian B. Hanson (Wayne, PA); Nicholas J. Ciccarelli (Philadelphia, PA); Sean M. O'Connor (West Chester, PA); Kevin Bokelman (San Diego, CA); Paul F. Bente, IV (Wayne, PA); John C. Love (San Diego, CA); Christopher Edward Hatch (San Diego, CA)
Assignee: UNL Holdings LLC
A61M5/14216A61M5/1454A61M5/14248A61M5/172A61M5/14566A61M2005/14252A61M2005/2474A61M2205/3317A61M2205/3379A61M2205/50A61M2205/58A61M2205/82
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,549,029
App. No.
15/625,563
Granted
Feb 4, 2020
Kind
B2
Abstract

A drive mechanism includes a housing, a piston adapted to impart movement to a plunger seal within a drug container, a plurality of biasing members disposed in parallel, and a retainer. The biasing members are disposed to release energy to cause movement of the piston from a retracted first position to the extended second position, the piston bearing against the plunger seal to dispense medicine. The retainer is disposed to maintain the biasing members in the energized position and to release the biasing members to permit the piston to dispense the medicine. The drive mechanism may also include an end-of-dose indicator to identify at least one of when the sleeve assembly is disposed subjacent a window in the housing the relative motion of the sleeve assembly with reference to the window or another reference component, the stoppage of such motion, and the rated or change of rate of motion.

Claims (20)

1. A drug pump drive mechanism for use in cooperation with a drug container including a plunger seal and a power and control system, the drive mechanism comprising: a drive housing defining an axis; a piston disposed for movement from at least a retracted first position to an extended second position along said axis, the piston adapted to impart movement to the plunger seal within the drug container; at least one biasing member disposed and adapted to cause movement of the piston from the retracted first position to the extended second position as the biasing member moves from an energized first position to a deenergized second position; a sleeve assembly disposed at least partially within the drive housing, at least a portion of the sleeve assembly being adapted to move along said axis with the piston; and an end-of-dose indicator, the end-of-dose indicator including a switch interconnect, the switch interconnect including a mechanical sensor adapted to selectively engage a portion of the sleeve assembly as a result of the movement of the piston from the retracted first position to the extended second position, the switch interconnect further being adapted to selectively engage the power and control system as a result of the engagement or disengagement of the sensor.

2. The drug pump drive mechanism as claimed in claim 1 , wherein the switch interconnect engages the power and control system when the trigger engages the sleeve assembly.

3. The drug pump drive mechanism as claimed in claim 1 , wherein the switch interconnect is disposed to selectively engage a PCB board of the power and control system dependent upon the position of the trigger relative to the sleeve assembly.

4. The drug pump drive mechanism as claimed in claim 1 , wherein the sleeve assembly has a trailing edge, and the mechanical trigger is disposed in a first position when the piston is in the retracted first position and a second position when the trailing edge of the sleeve assembly moves axially past the mechanical trigger.

5. The drug pump drive mechanism as claimed in claim 1 , wherein the sleeve assembly includes a plurality of telescoping sleeves.

6. The drug pump drive mechanism as claimed in claim 1 including at least two biasing members, the sleeve assembly being disposed about the at least two biasing members.

7. The drug pump drive mechanism as claimed in claim 1 , wherein the at least one biasing member includes a pair of compression springs.

8. The drug pump drive mechanism as claimed in claim 7 , wherein the compression springs are concentrically disposed.

9. The drug pump drive mechanism as claimed in claim 1 , wherein the mechanical sensor includes a pivotably mounted trigger.

10. The drug pump drive mechanism as claimed in claim 1 , wherein the mechanical sensor includes at least two pivotably mounted triggers, the switch interconnect further being adapted to selectively engage the power and control system as a result of the engagement or disengagement of any one of the at least two pivotably mounted triggers.

11. A drug pump comprising: a drug container including a plunger seal; a power and control system; a needle insertion mechanism; a fluid pathway connection; and a drive mechanism including: a drive housing defining an axis; a piston disposed for movement from at least a retracted first position to an extended second position along said axis, the piston adapted to impart movement to the plunger seal within the drug container; at least one biasing member disposed and adapted to cause movement of the piston from the retracted first position to the extended second position as the biasing member moves from an energized first position to a deenergized second position; a sleeve assembly disposed at least partially within the drive housing, at least a portion of the sleeve assembly being adapted to move along said axis with the piston; and an end-of-dose indicator, the end-of-dose indicator including a switch interconnect, the switch interconnect including a mechanical sensor adapted to selectively engage a portion of the sleeve assembly as a result of the movement of the piston from the retracted first position to the extended second position, the switch interconnect further being adapted to selectively engage the power and control system as a result of the engagement or disengagement of the sensor; wherein the power and control system initiates an end-of-dose indication as a result of the selective engagement of the switch interconnect.

12. The drug pump as claimed in claim 11 , wherein the switch interconnect engages the power and control system when the trigger engages the sleeve assembly.

13. The drug pump as claimed in claim 11 , wherein the switch interconnect is disposed to selectively engage a PCB board of the power and control system dependent upon the position of the trigger relative to the sleeve assembly.

14. The drug pump as claimed in claim 11 , wherein the sleeve assembly has a trailing edge, and the mechanical trigger is disposed in a first position when the piston is in the retracted first position and a second position when the trailing edge of the sleeve assembly moves axially past the mechanical trigger.

15. The drug pump as claimed in claim 11 , wherein the sleeve assembly includes a plurality of telescoping sleeves.

16. The drug pump as claimed in claim 11 including at least two biasing members, the sleeve assembly being disposed about the at least two biasing members.

17. The drug pump as claimed in claim 11 , wherein the at least one biasing member includes a pair of compression springs.

18. The drug pump as claimed in claim 11 , wherein there is a delay between the selective engagement of the switch interconnect and the initiation of the end-of-dose indication.

19. The drug pump as claimed in claim 11 , wherein the mechanical sensor includes a pivotably mounted trigger.

20. The drug pump as claimed in claim 11 , wherein the mechanical sensor includes at least two pivotably mounted triggers, the switch interconnect further being adapted to selectively engage the power and control system as a result of the engagement or disengagement of any one of the at least two pivotably mounted triggers.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 9, 2025
From: UNL HOLDINGS LLC
To: AMGEN INC.
Reel/Frame 073057/0641 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 4, 2017
From: UNILIFE CORPORATION; UNILIFE MEDICAL SOLUTIONS, INC.; UNITRACT SYRINGE PTY LTD ACN 101 059 723; UNILIFE MEDICAL SOLUTIONS PTY LIMITED ACN 008 071 403
To: UNL HOLDINGS LLC
Reel/Frame 044117/0961 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 22, 2017
From: AGARD, RYAN M.; HANSON, IAN B.; CICCARELLI, NICHOLAS J.; O'CONNOR, SEAN M.; BOKELMAN, KEVIN; BENTE, PAUL F., IV; LOVE, JOHN C.; HATCH, CHRISTOPHER EDWARD
To: UNITRACT SYRINGE PTY LTD
Reel/Frame 043663/0107 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 16, 2017
From: AGARD, RYAN M.; HANSON, IAN B.; CICCARELLI, NICHOLAS J.; O'CONNOR, SEAN M.; BOKELMAN, KEVIN; BENTE, PAUL F., IV; LOVE, JOHN C.; HATCH, CHRISTOPHER EDWARD
To: UNITRACT SYRINGE PTY LTD
Reel/Frame 042736/0687 →
Continuity (8)
Continuation 14230784 · Mar 31, 2014
Continuation In Part PCTUS2014013005 · Jan 24, 2014
Continuation In Part 14163690 · Jan 24, 2014
Continuation In Part 13600114 · Aug 30, 2012
Provisional Application 61756667 · Jan 25, 2013
Provisional Application 61912642 · Dec 6, 2013
Provisional Application 61530788 · Sep 2, 2011
Related Publication 20170281859A1 · Oct 5, 2017
Cited By (5)
US 1,122,440 US 12,226,613 US 12,396,752 US 12,533,298 US 12,691,213